Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.51 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.42 |
| ▸ | SOS1 | Q07889 | 3/20 | 0.41 |
| ▸ | KRAS | P01116 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HTR4 | Q13639 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6462625 | 0.85 | SIGMAR1 (0.52) | SIGMAR1ADRA1AADRA1B | |
| SCHEMBL6458570 | 0.82 | POLB (0.49) | ADRA1AADRA1B | |
| SCHEMBL6457124 | 0.81 | ADRA1D (0.50) | ADRA1DADRA1AADRA1B | |
| SCHEMBL6426288 | 0.81 | CNR2 (0.48) | — | |
| SCHEMBL6462987 | 0.78 | HTR7 (0.47) | ADRA1DADRA1AADRA1B | |
| SCHEMBL6466592 | 0.78 | HTR7 (0.55) | SIGMAR1ADRA1DADRA1AADRA1B | |
| SCHEMBL6461236 | 0.78 | HTR7 (0.46) | ADRA1DADRA1AADRA1B | |
| SCHEMBL6465657 | 0.78 | HTR7 (0.57) | ADRA1DADRA1AADRA1BHPGD | |
| SCHEMBL6470095 | 0.78 | EPHX2 (0.40) | SIGMAR1 | |
| SCHEMBL6472358 | 0.77 | DRD4 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1012147-B1 | O-SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC AGENTS | HOFFMANN LA ROCHE (CH) | 2005-11-02 | — | — | EP | disclosed |
| US-6200989-B1 | ADMINISTERING AS UROKINASE PLASMINOGEN ACTIVATOR ANTAGONISTS, ANTITUMOR AND ANTIMETASTASIS AGENTS | HOFFMANN-LA ROCHE INC. | 2001-03-13 | — | — | US | disclosed |